Portal Biotechnologies
Developer of a cell engineering platform designed to enable novel cell analytics and next generation cell therapies. The company is implementing a simplified approach to intracellular delivery, focuse...
Valuation
$34.8M
Market implied
Share Price
N/A
Total Raised
$12M
Last Round
N/A